-

Shareholder Alert: Robbins LLP Reminds Investors Tupperware Brands Corporation (TUP) Sued for Misleading Shareholders

SAN DIEGO & ORLANDO, Fla.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Tupperware Brands Corporation (NYSE: TUP) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between January 30, 2019 and February 24, 2020. Tupperware operates as a direct-to-consumer marketer of various products across a range of brands and categories in various regions.

If you suffered a loss as a result of Tupperware's misconduct, click here.

Tupperware Brands Corporation (TUP) Accused of Misleading Shareholders

According to the complaint, on February 26, 2019, Tupperware filed its annual report on Form 10-K for fiscal year 2018, concluding that "the Company's internal control over financial reporting was effective as of the end of the period covered by the report." Tupperware continued to attest to the accuracy of its financial reporting in later quarterly 2019 reports and repeatedly assured that there had been no changes in its internal controls. Despite these statements, on February 24, 2020, Tupperware announced that it would be unable to file its annual report for fiscal year ended December 28, 2019, revealing that it was "conducting an investigation primarily into accounting for accounts payable and accrued liabilities at its Fuller Mexico beauty business." The Company disclosed that total impairments for Fuller Mexico are expected to be approximately $31 million. Tupperware also stated "the Company is forecasting a need for relief concerning its existing leverage …its $650 million credit agreement… to avoid a potential acceleration of debt, which could have a material adverse impact on the Company." On this news, Tupperware's stock price plummeted 45.6% to close at $3.11.

Tupperware Brands Corporation (TUP) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
LKandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leonid Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:TUP

Release Versions
$Cashtags

Contacts

Leonid Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Snowflake Inc. Class Action Reminder - Robbins LLP Encourages SNOW Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Snowflake Inc. (NYSE: SNOW) Class A common stock between June 27, 2023 and February 28, 2024. Snowflake is a software company that provides cloud data storage that enables customers to consolidate data onto data-driven applications and share data for the purpose of running analytics and other processes. For more information, submit a form, ema...

Corcept Therapeutics Incorporated Class Action Reminder – Robbins LLP Encourages CORT Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025. Corcept is a pharmaceutical company focused on the development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol.For more information, submit a...

uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.What is the class period? September 24, 2025 – October 31, 2025What...
Back to Newsroom